Cher M Dallal1, Louise A Brinton, Charles E Matthews, Ruth M Pfeiffer, Terryl J Hartman, Jolanta Lissowska, Roni T Falk, Montserrat Garcia-Closas, Xia Xu, Timothy D Veenstra, Gretchen L Gierach. 1. 1Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD; 2Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD; 3Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD; 4Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD; 5Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA; 6M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, POLAND; 7Division of Breast Cancer Research, Division of Genetics and Epidemiology and Breakthrough Breast Cancer Centre, The Institute of Cancer Research, London, UNITED KINGDOM; 8Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD; and 9C2N Diagnostics, Saint Louis, MO.
Abstract
PURPOSE: Physical activity may reduce endogenous estrogens, but few studies have assessed effects on estrogen metabolism and none have evaluated sedentary behavior in relation to estrogen metabolism. We assessed relationships between accelerometer-measured physical activity and sedentary behavior and 15 urinary estrogens and estrogen metabolites (EM) among postmenopausal controls from a population-based breast cancer case-control study conducted in Poland (2000-2003). METHODS: Postmenopausal women (N = 542) were ages 40 to 72 yr and not currently using hormone therapy. Accelerometers, worn for 7 d, were used to derive measures of average activity (counts per day) and sedentary behavior (<100 counts per minute per day). Estrogen metabolites were measured in 12-h urine samples using liquid chromatography-tandem mass spectrometry. Estrogen metabolites were analyzed individually, in metabolic pathways (C-2, -4, or -16), and as ratios relative to parent estrogens. Geometric means of estrogen metabolites by tertiles of accelerometer-measures, adjusted for age and body mass, were computed using linear models. RESULTS: High activity was associated with lower levels of estrone and estradiol (P trend = 0.01), whereas increased sedentary time was positively associated with these parent estrogens (P trend = 0.04). Inverse associations were observed between high activity and 2-methoxyestradiol, 4-methoxyestradiol, 17-epiestriol, and 16-epiestriol (P trend = 0.03). Sedentary time was positively associated with methylated catechols in the 2- and 4-hydroxylation pathways (P trend ≤ 0.04). Women in the highest tertile of activity had increased hydroxylation at the C-2, -4, and -16 sites relative to parent estrogens (P trend ≤ 0.02), whereas increased sedentary time was associated with a lower 16-pathway/parent estrogen ratio (P trend = 0.01). CONCLUSIONS: Higher activity was associated with lower urinary estrogens, possibly through increased estrogen hydroxylation and subsequent metabolism, whereas sedentary behavior may reduce metabolism.
PURPOSE: Physical activity may reduce endogenous estrogens, but few studies have assessed effects on estrogen metabolism and none have evaluated sedentary behavior in relation to estrogen metabolism. We assessed relationships between accelerometer-measured physical activity and sedentary behavior and 15 urinary estrogens and estrogen metabolites (EM) among postmenopausal controls from a population-based breast cancer case-control study conducted in Poland (2000-2003). METHODS: Postmenopausal women (N = 542) were ages 40 to 72 yr and not currently using hormone therapy. Accelerometers, worn for 7 d, were used to derive measures of average activity (counts per day) and sedentary behavior (<100 counts per minute per day). Estrogen metabolites were measured in 12-h urine samples using liquid chromatography-tandem mass spectrometry. Estrogen metabolites were analyzed individually, in metabolic pathways (C-2, -4, or -16), and as ratios relative to parent estrogens. Geometric means of estrogen metabolites by tertiles of accelerometer-measures, adjusted for age and body mass, were computed using linear models. RESULTS: High activity was associated with lower levels of estrone and estradiol (P trend = 0.01), whereas increased sedentary time was positively associated with these parent estrogens (P trend = 0.04). Inverse associations were observed between high activity and 2-methoxyestradiol, 4-methoxyestradiol, 17-epiestriol, and 16-epiestriol (P trend = 0.03). Sedentary time was positively associated with methylated catechols in the 2- and 4-hydroxylation pathways (P trend ≤ 0.04). Women in the highest tertile of activity had increased hydroxylation at the C-2, -4, and -16 sites relative to parent estrogens (P trend ≤ 0.02), whereas increased sedentary time was associated with a lower 16-pathway/parent estrogen ratio (P trend = 0.01). CONCLUSIONS: Higher activity was associated with lower urinary estrogens, possibly through increased estrogen hydroxylation and subsequent metabolism, whereas sedentary behavior may reduce metabolism.
Authors: Charles E Matthews; Kong Y Chen; Patty S Freedson; Maciej S Buchowski; Bettina M Beech; Russell R Pate; Richard P Troiano Journal: Am J Epidemiol Date: 2008-02-25 Impact factor: 4.897
Authors: Heather K Neilson; Christine M Friedenreich; Nigel T Brockton; Robert C Millikan Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-01 Impact factor: 4.254
Authors: C E Matthews; P S Freedson; J R Hebert; E J Stanek; P A Merriam; M C Rosal; C B Ebbeling; I S Ockene Journal: Am J Epidemiol Date: 2001-01-15 Impact factor: 4.897
Authors: Barbara J Fuhrman; Catherine Schairer; Mitchell H Gail; Jennifer Boyd-Morin; Xia Xu; Laura Y Sue; Saundra S Buys; Claudine Isaacs; Larry K Keefer; Timothy D Veenstra; Christine D Berg; Robert N Hoover; Regina G Ziegler Journal: J Natl Cancer Inst Date: 2012-01-09 Impact factor: 13.506
Authors: A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-10-20 Impact factor: 4.254
Authors: I-Min Lee; Eric J Shiroma; Felipe Lobelo; Pekka Puska; Steven N Blair; Peter T Katzmarzyk Journal: Lancet Date: 2012-07-21 Impact factor: 79.321
Authors: Joshua N Sampson; Roni T Falk; Catherine Schairer; Steven C Moore; Barbara J Fuhrman; Cher M Dallal; Douglas C Bauer; Joanne F Dorgan; Xiao-Ou Shu; Wei Zheng; Louise A Brinton; Mitchell H Gail; Regina G Ziegler; Xia Xu; Robert N Hoover; Gretchen L Gierach Journal: Cancer Res Date: 2016-12-23 Impact factor: 12.701
Authors: Sophia A Stone; Claire J Han; Taurence Senn; Larissa A Korde; Kristen Allott; Scott Reding; Dale Whittington; Kerryn W Reding Journal: West J Nurs Res Date: 2019-01-07 Impact factor: 1.967
Authors: Sarah J O Nomura; Chiranjeev Dash; Vanessa B Sheppard; Deborah Bowen; Matthew Allison; Wendy Barrington; Rowan Chlebowski; Mace Coday; Lifang Hou; Barbara Howard; Michael LaMonte; JoAnn E Manson; Marian L Neuhouser; Electra Paskett; Maryam Sattari; Marcia Stefanick; Jean Wactawski-Wende; Lucile L Adams-Campbell Journal: Cancer Causes Control Date: 2017-10-03 Impact factor: 2.506
Authors: Hannah Oh; Hannah Arem; Charles E Matthews; Nicolas Wentzensen; Kerryn W Reding; Louise A Brinton; Garnet L Anderson; Sally B Coburn; Jane A Cauley; Chu Chen; Deborah Goodman; Ruth M Pfeiffer; Roni T Falk; Xia Xu; Britton Trabert Journal: Br J Cancer Date: 2017-08-17 Impact factor: 7.640
Authors: Ximena M Bustamante-Marin; Jenna L Merlino; Emily Devericks; Meredith S Carson; Stephen D Hursting; Delisha A Stewart Journal: Front Endocrinol (Lausanne) Date: 2021-03-17 Impact factor: 6.055
Authors: Brian Perry; Will Herrington; Jennifer C Goldsack; Cheryl A Grandinetti; Kaveeta P Vasisht; Martin J Landray; Lauren Bataille; Robert A DiCicco; Corey Bradley; Ashish Narayan; Elektra J Papadopoulos; Nirav Sheth; Ken Skodacek; Komathi Stem; Theresa V Strong; Marc K Walton; Amy Corneli Journal: Digit Biomark Date: 2018-01-31